JSL Health Capital | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/JSL Health Capital/Activity

JSL Health Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Investor in Network Bio's $50M launch financing to build disease-specific AI models from patient tissue data.

Network Bio

Network Bio JSL Health Capital

morningstar.comAUG 19, 2026

AUG 19, 2026

Exit

Portfolio company d2i, an ED/EMS data analytics platform, was acquired by ESO Solutions.

d2i

d2i JSL Health Capital

eso.comAPR 7, 2026

APR 7, 2026

Investment

Investor in Beacon Biosignals' upsized Series B, bringing the round to over $97M.

Beacon Biosignals

Beacon Biosignals JSL Health Capital

beacon.bioAPR 2026

APR 2026

Exit

Portfolio company Rippl Care was acquired by Harbor Health.

Rippl Care

Rippl Care JSL Health Capital

prnewswire.comFEB 2026

FEB 2026

4 investments· JAN 2025 – DEC 2025Show all

Investment

Investor in Radial's $50M Series A, led by General Catalyst, to expand access to brain medicine.

Radial

Radial JSL Health Capital

prnewswire.comDEC 9, 2025

DEC 9, 2025

Investment

Led Synfini's $8.9M discovery funding round to speed small-molecule drug development.

Synfini

Synfini JSL Health Capital

globenewswire.comJUL 7, 2025

JUL 7, 2025

Investment

Investor in General Medicine's $32M raise for its AI-era healthcare storefront.

General Medicine

General Medicine JSL Health Capital

prnewswire.comMAY 2025

MAY 2025

Investment

New investor in Bicycle Health's $16.5M raise to scale virtual opioid use disorder treatment.

Bicycle Health

Bicycle Health JSL Health Capital

globenewswire.comJAN 29, 2025

JAN 29, 2025